Year: 2008
Type: article
Abstract: In-vivo T2-weighted CMR delineates the area at risk (AAR) and can be used in conjunction with delayed contrast enhancement to evaluate infarct reduction therapies.
Authors: Anthony H Aletras, Peter Kellman, Li-Yueh Hsu, Robert F Hoyt, Andrew E Arai
Institution: National Institutes of Health
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W2079328830
